Abrocitinib 'safe, effective' for atopic dermatitis, industry study finds
Researchers report on results from a phase three trial that includes adolescents
The investigational drug abrocitinib is safe and effective for treating moderate to severe atopic dermatitis in adolescents and adults, an industry trial shows.